Monsanto's Guidance Grows Like a Weed

Recs

1

It's a new month, so like clockwork, we get another press release from Monsanto (NYSE: MON) announcing higher guidance. The agricultural giant isn't sending out nickel-and-dime information to get free media coverage. These guidance increases are legitimate reasons to let investors know that it's doing well.

Full-Year Guidance

Low-End Increase

Jan.

$2.50 to $2.60

14%

Feb.

$2.70 to $2.80

8%

March

$3.15 to $3.25

17%

The January increase in guidance came in conjunction with Monsanto's stellar fiscal-first-quarter results, as sales in the Southern Hemisphere came in better than expected.

February's increase came in conjunction with the company's presentation at Goldman Sachs' 2008 AgForum Conference -- you've got to give the analysts something to chew on. Increased sales of RoundUp herbicides, as well as corn and soybean seed sales, caused the expected uptick in earnings.

Some of the most recent bump in guidance -- $0.23 per share, to be exact -- comes from money Monsanto receives in conjunction with its spinoff Solutia's (NYSE: SOA) emergence from bankruptcy. That's a one-time event, but there's still quite a bit of revenue growth baked into the rest of the guidance bump.

The company expects sales of both seeds and RoundUp to increase even more than previously expected. The increased global demand for RoundUp likely means that additional acres are being planted, which bodes well for DuPont (NYSE: DD), Potash (NYSE: POT), Mosaic (NYSE: MOS), and the rest of the agriculture industry.

Monsanto is now looking for full-year earnings more than 50% greater than last fiscal year's adjusted earnings. While that's great in the near term -- it's pushed Monsanto's stock up nearly 30% since last year's financials were released -- I'm not sure it can last. The company's short-term growth is tied to commodity prices. I'm not willing to call the top of the commodity bull market, but it has to end eventually ... doesn't it?

Throw on some overalls and plant your eyes on this Foolishness:

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 607158, ~/Articles/ArticleHandler.aspx, 11/9/2009 10:57:02 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:00 PM
DD $34.61 Up +1.23 +3.68%
E.I. du Pont de Ne… CAPS Rating: ****
MON $70.00 Up +0.86 +1.24%
Monsanto Company CAPS Rating: ****
MOS $50.22 Up +1.17 +2.39%
The Mosaic Company CAPS Rating: ****
POT $99.67 Up +3.42 +3.55%
Potash Corp./Saska… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Writedown: A writedown is a non-cash expense that reduces the value of an asset on the balance sheet.

Want to learn more or edit this definition?
Click here to read more!